Sustained Release Drugs Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Sustained Release Drugs Market is expected to gain growth at a potential rate of 8% in the forecast period of 2022 to 2028. 

Sustained release drugs offer several advantages over conventional drugs. These include better patient compliance, lower dosing frequency, reduced side effects, and lower overall cost of care. Depending on the therapeutic need, flexible drug formulations can be designed to provide immediate release, delayed release, or sustained release. Sustained-release formulations are designed to release a drug at a set rate by maintaining a constant drug concentration for a set period of time. The most commonly used drug delivery systems for sustained release drugs are parenteral injections and implants.

Market Segments

By Route of Administration

• Oral
• Intramuscular
• Subcutaneous
• Transdermal
• Intravenous

By Mode

• Over-the-Counter
• Prescription

Key Players

• Pfizer, Inc.
• Sanofi
• Endo Pharmaceuticals, Inc.
• Janssen Global Services, LLC
• Eli Lilly and Company
• Alkermes
• Genentech, Inc.
• Novartis AG
• Abbott
• Ipsen Pharma

Scope of the Report

The research study analyzes the global Sustained Release Drugs industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Sustained Release Drugs Market Report

1. What was the Sustained Release Drugs Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Sustained Release Drugs Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Sustained Release Drugs Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.